Overview
Summit Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of patient-, physician-, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. Summit’s current development pipeline consists of drug candidates focused on C. difficile infection and infections caused by Carbapenem-resistant Enterobacteriaceae (CRE).